Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print July 10, 2007
DOI: 10.2337/db06-1731

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1731v1
56/10/2449    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, Z.
Right arrow Articles by Mitch, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, Z.
Right arrow Articles by Mitch, W. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

PTEN expression contributes to the regulation of muscle protein degradation in diabetes

Zhaoyong Hu, In Hee Lee, Xiaonan Wang*, Hongmiao Sheng**, Jie Du, and William E. Mitch

Nephrology Division, Baylor College of Medicine, Houston, TX
* Renal Division, Emory University School of Medicine, Atlanta, GA
** Departments of Surgery, Indiana University School of Medicine, Indianapolis, IN

Correspondence: zhaoyonh{at}bcm.edu

Objective:Conditions accelerating muscle proteolysis are frequently associated with defective phosphatidylinositol 3-kinase (PI3K)/Akt signaling and reduced PI3K-generated PIP3 (phosphatidylinositol [3,4,5] triphosphate). We evaluated the control of muscle protein synthesis and degradation in mouse models of type 1 and 2 diabetes to determine if defects besides PI3K/Akt activities affect muscle metabolism.

Research Design and Methods:We evaluated the expression and activity of PTEN, the phosphatase converting PIP3 to inactive PIP2 and studied how PTEN influences muscle protein in diabetic wild type mice and mice with partial deficiency of PTEN(+/-).

Results:In acutely diabetic mice, muscle PTEN expression was decreased. It was increased by chronic diabetes or insulin resistance. In cultured C2C12 myotubes, acute suppression of PI3K activity led to decreased PTEN expression while palmitic acid increased PTEN in myotubes in a p38-dependent fashion. To examine if PTEN affects muscle protein turnover, we studied primary myotubes cultures from wild-type and PTEN(+/-) mice. The proteolysis induced by serum deprivation was suppressed in PTEN(+/-) cells. Moreover, the sizes of muscle fibers in PTEN(+/-) mice and wild-type mice were similar but, the increase in muscle proteolysis caused by acute diabetes was significantly suppressed by PTEN(-/+). This anti-proteolytic response involved higher PIP3 and p-Akt levels and a decrease in caspase-3-mediated actin cleavage and activation of the ubiquitin-proteasome system as signified by reduced induction of Atrogin-1/MAFbx or MurF1 indicating.

Conclusions:Changes in PTEN expression participate in the regulation of muscle proteolytic pathways. A decrease in PTEN could be a compensatory mechanism to prevent muscle protein losses.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.